Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Biomedicines ; 10(11)2022 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-36428504

RESUMO

Tobacco consumption is the most incriminated and studied risk factor for Chronic obstructive pulmonary disease (COPD), but other factors such as air pollution, are also linked to this disease. One of the known aspects of this chronic lung disease is that its occurrence is mainly due to the chronic inflammation of the airways. Lipid metabolism seems to be affected by smoking, with studies showing a correlation between this habit and high levels of triglycerides and low levels of high-density lipoprotein cholesterol (HDL-CHOL). Uric acid concentration is thought to reflect the antioxidative capacity of the body because it is the most abundant aqueous antioxidant. The aim of this study was to investigate the lipid profile and biochemical parameters of COPD patients in relation to smoking status. The present study was conducted between 2020 and 2021 in the Clinical Hospital of Pneumology in Iasi, Romania. Patients diagnosed with COPD (n = 52) were included and divided in three groups depending on their smoking status: non-smokers, smokers and ex-smokers. The obtained results show low correlations between COPD stages and serum uric acid concentrations (r = 0.4; p ˂ 0.05), smoking status (smoker/non-smoker/ex-smoker) and total serum cholesterol values (r = 0.45; p ˂ 0.05), but also between serum urea concentrations and the number of packs-years for the smoker/ex-smoker groups (r = 0.45, p ˂ 0.05). Smoking was associated with changes in the lipid profile of smokers and ex-smokers, along with increased low-density lipoprotein cholesterol (LDL-CHOL) and low serum uric acid values.

2.
Rom J Morphol Embryol ; 62(1): 73-83, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34609410

RESUMO

OBJECTIVE: Identifying the morphological features of thymus in patients with myasthenia gravis (MG) with anti-acetylcholine receptor (AChR) antibodies and concomitant Hashimoto's thyroiditis (HT), which were recruited from a single surgical unit of a tertiary referral hospital located in the North-Eastern region of Romania, over a period of 11 years. PATIENTS, MATERIALS AND METHODS: We retrospectively reviewed clinical, imaging, laboratory, thymic pathology, and outcome data that were obtained from medical records of patients with MG and concomitant HT, to whom a thymectomy was performed for a suspected thymic lesion. All the surgical interventions were done in the Third Clinic of Surgery, St. Spiridon Emergency County Hospital, Iasi, Romania, for an 11 years' period, i.e., from January 1, 2000 and December 31, 2010. RESULTS: Four patients (three females and one male) were included. The mean age of the patients at the time of their thymectomy was 40.25 years. Of all patients, 75% had moderate or severe MG, 100% had anti-AChR antibodies, and an electromyographic decrement greater than 25%. All patients have been diagnosed with HT in their past medical history by a full thyroid panel [high thyroid-stimulating hormone (TSH) values, low free thyroxine (fT4) values, and the presence of the anti-thyroid antibodies] and all of them have been treated with Euthyrox. Our four patients expressed different MG subtypes, each of them being associated with different thymus pathology. Thoracic computed tomography (CT) scan revealed heterogeneous mediastinal masses and established the correct diagnosis only in 25% of cases. The pathological exams also revealed a heterogeneous pattern of thymic lesions. In contrast with other studies, our patients with MG with anti-AChR antibodies and concomitant HT presented atrophic thymus more frequently (50%), but with particular morphological changes of Hassall's corpuscles. Also, 25% of cases were diagnosed with thymic lympho-follicular hyperplasia (TLFH) associated with thymic epithelial hyperplasia. In B2 thymoma, neoplastic epithelial cells expressed cytokeratin 19 (CK19) immunoreactivity, high Ki67 labeling index and strong p63 immunopositivity. CONCLUSIONS: In our series, MG and HT occurred simultaneously, or one of them was diagnosed before the other, raising some new questions regarding the immune mechanism of these two autoimmune diseases. Due to the heterogeneous morphological changes of the thymus that we found in this study, we can hypothesize that thymus is involved in the pathogenic mechanism of MG with anti-AChR-antibodies and concomitant HT development.


Assuntos
Doença de Hashimoto , Miastenia Gravis , Neoplasias do Timo , Adulto , Feminino , Humanos , Masculino , Miastenia Gravis/complicações , Receptores Colinérgicos , Estudos Retrospectivos
3.
World J Clin Cases ; 8(18): 4162-4168, 2020 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-33024774

RESUMO

BACKGROUND: Lung and airway involvement in inflammatory bowel disease are increasingly frequently reported either as an extraintestinal manifestation or as an adverse effect of therapy. CASE SUMMARY: We report a case of a patient with ulcerative colitis controlled under mesalazine treatment who presented with chronic cough and hemoptysis. Chest computed tomography and bronchoscopy findings supported tracheal involvement in ulcerative colitis; pathology examination demonstrated an unusual eosinophil-rich inflammatory pattern, and together with clinical data, a nonasthmatic eosinophilic bronchitis diagnosis was formulated. Full recovery was observed within days of mesalazine discontinuation. CONCLUSION: Mesalazine-induced eosinophilic respiratory disorders have been previously reported, generally involving the lung parenchyma. To the best of our knowledge, this is the first report of mesalamine-induced eosinophilic involvement in the upper airway.

4.
Tob Prev Cessat ; 4: 13, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-32411841

RESUMO

INTRODUCTION: The 2017 Tobacco Cessation Guidelines for High-risk Groups (TOB-G) is a comprehensive document on best practices for smoking cessation in clinical practice. The purpose of this pilot study was to assess physician satisfaction and changes in tobacco-related knowledge, self-efficacy and attitudes following exposure to training in the TOB-G guidelines for patients with cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD), or diabetes. METHODS: A pre-post pilot study was conducted. All participating physicians received an electronic or printed copy of the TOB-G guidelines for patients with CVD, COPD or diabetes. Physicians were also exposed to a one-day training focused on the key clinical practice recommendations from the TOB.g guidelines. Outcome measurement occurred via survey before, immediately following and 6 months after exposure to the training. RESULTS: Fifty physicians participated in the TOB.g training session. High rates of participant satisfaction were documented (exceeded expectations 47.7%; met expectations to a great extent 52.3%). Significant increases in physician knowledge and self-efficacy were documented immediately following and 6 months after exposure to the guideline training session. Exposure to the training was associated with positive changes in some but not all tobacco-related treatment attitudes, however these were no longer significant at the 6-month follow-up. Lower knowledge, confidence and unfavourable attitudes were documented for aspects of treatment related to pharmacotherapy. CONCLUSIONS: Positive changes in previously reported barriers to the delivery of tobacco treatment among physicians were documented following exposure to the TOB.g guidelines and training for patients with CVD, COPD or diabetes.

5.
Rom J Morphol Embryol ; 58(2): 537-544, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28730240

RESUMO

PURPOSE: Chronic dacryocystitis (CD) is an inflammation of the lacrimal sac and nasolacrimal duct with a long-standing evolution. The aims of this study were to analyze the epidemiology and to evaluate the histopathological features and the chronic inflammation score (CIS) system of chronic dacryocystitis in the region of Moldavia, Romania, over a period of 16 years. METHODS: We conducted a retrospective descriptive analysis of all pathological reports of chronic dacryocystitis from the Department of Pathology, "Prof. Dr. Nicolae Oblu" Emergency Clinical Hospital, Iasi, Romania, between January 1, 1999 and December 31, 2015, with the final application of CIS. We also recorded the demographic information of patients and lesion localizations. RESULTS: Eighteen cases of CD were identified, with a female:male ratio of 8:1. Patient median age was 66.27 years (range 33-83 years), 55.55% being in their eighth and ninth decade of life. A non-systemized growth trend starting with 2002 could be identified. Microscopically, several histopathological features were identified, some of them being associated: epithelial lining hyperplasia with pseudopapillary folds (77.77% of the cases), epithelial invaginations in the submucosa (11.11%), squamous metaplasia (16.66%) or partial denudation (33.33%). The sac wall revealed chronic diffusion (88.88%) or nodular lymphocytic inflammation (11.11%). 5.55% of cases presented fibrosis in the lacrimal sac wall with few lymphocytes. Applying CIS system, the majority of cases (13 patients, 72.22%) were identified with moderate chronic inflammation, only one case (5.55%) pointed out a mild degree of inflammation with a CIS<3, but four (22.22%) cases showed severe inflammatory changes with a CIS>6. CONCLUSIONS: In our region, CD is more frequent in senior women, probably due to their deficient immune system. Histological specimens of CD are not commonly found in practice of pathologists, but when the histological sections are analyzed they reflect a multitude of aspects that need to be known in order to guide ophthalmologists in their practice. In our region, CD is more frequent in senior women, probably due to their deficient immune system and to the specific anatomy of their nasolacrimal duct. The histological appearances varied from patient to patient and even in the same patient varied from one area to another. There were histopathological changes indicating adaptive changes, which could lead to the development of malignant tumors at this level. Therefore, there is a need for patient education with CD both in terms of ophthalmic hygiene and in what regards possible complications in the absence of a regular presentation to the ophthalmologist.


Assuntos
Dacriocistite , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Doença Crônica , Dacriocistite/epidemiologia , Dacriocistite/patologia , Feminino , Humanos , Inflamação/patologia , Masculino , Pessoa de Meia-Idade , Moldávia , Estudos Retrospectivos , Romênia , Fatores de Tempo
6.
Rom J Morphol Embryol ; 58(2): 671-680, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28730260

RESUMO

In recent years, there is a growing evidence that using 5-aminolevulinic acid (5-ALA)-guided resection of a cerebral glioblastoma, associated with chemoradiotherapy determine a prolonged survival of these patients, even though this period do not exceed 15 months. 5-ALA is a natural biochemical precursor of heme that is metabolized to fluorescent porphyrins, particularly protoporphyrin IX (PPIX) and no foreign reaction were noted until now. However, foreign body reaction developing in neurosurgery is documented in a few number of cases to suture material, surgical hemostatic material, or surgical glove starch, but up to now we could not find any article about granulomatous inflammation to polyglycolic acid (PGA) suture after brain tumor resection. Here we present a case of a delayed foreign body granuloma to PGA suture diagnosed after 10 months following fluorescence-guided surgery with 5-ALA for resection of a cerebral glioblastoma that was difficult to diagnosis both clinically and on magnetic resonance imaging (MRI). Moreover, the survival time was longer. We correlate the appearance of foreign body granuloma with the patient's persistent pre- and postoperative lymphocytosis. We also suggest that the chronic inflammation inhibited the proliferation of any tumoral cells which could remain in the tumor bed because we did not noticed on serial MRI scans a rapidly tumor growth during the first 10 months after the initial surgery as we have expected to be for a glioblastoma.


Assuntos
Ácido Aminolevulínico/uso terapêutico , Glioblastoma/cirurgia , Ácido Poliglicólico/efeitos adversos , Suturas/estatística & dados numéricos , Ácido Aminolevulínico/farmacologia , Encéfalo/patologia , Glioblastoma/mortalidade , Glioblastoma/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Ácido Poliglicólico/uso terapêutico , Análise de Sobrevida
7.
Rev Med Chir Soc Med Nat Iasi ; 120(1): 48-54, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27125072

RESUMO

UNLABELLED: A wide range of pharmaceutical substances can induce side-effects expressed as cardiovascular changes or events, adding to other risk factors or worsening preexisting cardiovascular diseases. AIM: Continuous study focused on iatrogenic conditions representing cardiovascular risk factors. METHODS: We developed a descriptive study of patients admitted to the Iasi Vth Internal Medicine and Geriatrics-Gerontology Clinic between 1998-2013, focusing on iatrogenic conditions representing cardiovascular risk factors. RESULTS: We have diagnosed 81 cases of drug-induced hypertension, and 43 patients with hypertensive crises; 72 cases of iatrogenic hyperglycemia; 36 cases of drug-induced hyperuricemia; 50 cases of drug-induced dyslipidemias; and 17 cases of iatrogenic obesity. These iatrogenic diseases were more common in women and the elderly. Twenty-eight patients have developed simultaneous adverse drug reactions induced by the same drug and manifest as different cardiovascular risk factors. CONCLUSIONS: Cardiovascular risk factors can be induced to a significant extent by chronic drug administration. Some medications (e.g., NSAIDs, corticoids, beta-blockers, diuretics, contraceptives) can act on the same patient by multiple pathogenic links. The adverse drug reactions can be cardiovascular risk factors that persist in time, or can be removed (by discontinuing the administration of the implicated drug). The highest importance of their acknowledgment relies on the possibility of their prevention through carefully balancing the benefits and the risk of each new medication.


Assuntos
Fármacos Cardiovasculares/efeitos adversos , Doenças Cardiovasculares/induzido quimicamente , Doenças Cardiovasculares/prevenção & controle , Diabetes Mellitus/induzido quimicamente , Diuréticos/efeitos adversos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Dislipidemias/induzido quimicamente , Hiperuricemia/induzido quimicamente , Obesidade/induzido quimicamente , Idoso , Índice de Massa Corporal , Feminino , Seguimentos , Humanos , Hipertensão/induzido quimicamente , Masculino , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Romênia , Fatores de Tempo
8.
Rev Med Chir Soc Med Nat Iasi ; 115(2): 331-6, 2011.
Artigo em Romano | MEDLINE | ID: mdl-21870719

RESUMO

UNLABELLED: The aim of this study was to reveal if there are connections between depression and cardiovascular disease. MATERIAL AND METHOD: We have studied 413 patients from Jorasti, Jud Galati on a two-years period (2008-2010). On these patients there was performed a careful history taking and they were physically examined (height, weight, body mass index, waist, blood pressure, heart rate). There was also performed an ECG (electrocardiogram), there were measured the levels of cholesterolemia, HDL-cholesterolemia, trygliceridemia and creatininemia. We used the Geriatric Depression Scale (GDS) in order to evaluate depression. RESULTS: in these patients there was noticed a higher prevalence of dyslipidemias, obesity and depression in women. Out of the 46 women with mild and severe depression 32 are overweight, 7 have obesity, 29 a high cholesterol, 23 a high LDL-cholesterol; all of them had a high risk or the presence of cardiovascular disease. CONCLUSIONS: Depression is an independent risk factor for producing a cardiovascular event; the level of cholesterol and of the blood preessure was higher in patients with severe depression, proving that the level of the cardiovascular risk factors increased with the severity of the depression. Treating the elderly, which often associate depression, makes necessary a careful evaluation of all comorbidities and risks, in order to establish perfect individualized strategies of improving the quality of life.


Assuntos
Envelhecimento , Doenças Cardiovasculares/psicologia , Depressão/complicações , Fatores Etários , Idoso , Biomarcadores/sangue , Índice de Massa Corporal , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/epidemiologia , Colesterol/sangue , HDL-Colesterol/sangue , Depressão/sangue , Depressão/diagnóstico , Depressão/epidemiologia , Feminino , Avaliação Geriátrica , Humanos , Hipertensão/complicações , Masculino , Anamnese , Pessoa de Meia-Idade , Obesidade/complicações , Sobrepeso/complicações , Exame Físico , Prevalência , Estudos Retrospectivos , Fatores de Risco , Romênia/epidemiologia , Índice de Gravidade de Doença , Triglicerídeos/sangue
9.
Rev Med Chir Soc Med Nat Iasi ; 114(4): 977-81, 2010.
Artigo em Romano | MEDLINE | ID: mdl-21500446

RESUMO

UNLABELLED: The aim of the study was to evaluate dislypidemias as risk factor in the countryside. MATERIAL AND METHOD: There have been evaluated 413 patients from the countryside (Jorasti, Galati County), in the period 2008-2010. There was performed history taking, physical examination, an ECG and biological findings (glycemia, colesterolemia, HDL-colesterolemia, trygliceridemia, creatinenemia). RESULTS: In these patients there was noticed a higher prevalence of the dislypidemias in women (65.7%) than in men (50.29%). Both dislypidemias and hypertension were more frequent in patients with cardiovascular disease or in those with high risk of cardiovascular disease than in those with a small or absent risk both in men and in women. In 208 cases there have been present all the elements of the metabolic syndrome. CONCLUSIONS: The modifiable risk factors have a very important part in the development of cardiovascular diseases in the countryside. Using proper programmes of prophylaxis there can be hope for a decrease of the morbidity and mortality of cardiovascular disease.


Assuntos
Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Dislipidemias/complicações , Dislipidemias/epidemiologia , Lipídeos/sangue , Biomarcadores/sangue , Glicemia/metabolismo , Doenças Cardiovasculares/sangue , Colesterol/sangue , HDL-Colesterol/sangue , Creatinina/sangue , Dislipidemias/sangue , Eletrocardiografia , Feminino , Humanos , Hipertensão/epidemiologia , Masculino , Anamnese , Exame Físico , Prevalência , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Romênia/epidemiologia , População Rural/estatística & dados numéricos , Distribuição por Sexo , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA